According to a report by a market research institution P&S Intelligence, the Europe DOA testing market is growing at a rapid pace, and will continue like this in the future.

The main factors driving the industry growth are increasing government initiatives, rising awareness among youth regarding drug and alcohol addiction problems, and tech progressions in DOA testing products. 

Based on the offering, the services category is experiencing faster growth. The adoption of drug testing at workplaces, and major players focusing on providing testing services are the main factors boosting the growth in this category.

Drug abuse testing can be done through saliva, hair, urine, and other samples. Among these, the most commonly used sample type is urine, and it contributed substantially  to the industry  to this industry in the past. 

Browse detailed report - Europe Drug of Abuse (DOA) Testing Markett Analysis and Demand Forecast Report

The major market players in the region are trying for mergers and acquisitions leading to the improvement of their service offering and product portfolio. 

Some of the leading European DOA testing industry players are Quest Dianostics Inc., Merck KGaA, Thermo Fisher Scientific, Siemens AG, Danaher Corporation, Lipomed AG, Psychemdics, Abbott Laboratories, Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories Inc., F. Hoffman-La Roche Ltd., and Express Diagnostics Int’l Inc. 

Due to the increasing incidence of alcohol-related problems, rising awareness of DOA testing, and tech advancement, the industry in Europe will grow significantly in the coming years.